Partial-thickness scalds in children: A comparison of different treatment strategies
- PMID: 28040360
- DOI: 10.1016/j.burns.2016.10.009
Partial-thickness scalds in children: A comparison of different treatment strategies
Abstract
Aim: The aim of this study was to compare the clinical outcomes of different treatment strategies for children with partial-thickness scalds at two burn centers. At the first burn center, these burns were treated with a hydrofiber dressing (Aquacel®, Convatec, Inc.®, Princeton, NJ, USA) or silver sulfadiazine (SSD, Flammazine®, Sinclair IS Pharma, London, UK Pharmaceuticals), while at the second burn center, cerium nitrate-silver sulfadiazine (CN-SSD, Flammacerium®, Sinclair IS Pharma, London, UK Pharmaceuticals) was used.
Methods: A two-center retrospective study was conducted of children admitted between January 2009 and December 2013 for partial-thickness scalds up to 10% TBSA who were treated primarily with a hydrofiber dressing or silver sulfadiazine (Burn Center Rotterdam) vs. cerium nitrate-silver sulfadiazine (Burn Center Groningen). The Dutch Burn Repository R3 and the electronic medical records of the study population were used for data extraction. The primary outcome was the time to wound healing. The secondary outcomes were the length of hospital stay, wound infection, and surgical treatment.
Results: The time to wound healing differed between the groups (HR=1.46, 95%CI 1.17-1.82); the shortest time to wound healing was observed in the patients treated with CN-SSD (median 13 days), compared with 15 days for the patients treated with hydrofiber and 16 days for the patients treated with SSD (p<0.01). The length of stay was significantly shorter for the hydrofiber patients (medians: hydrofiber 3 days, SSD 10 days and CN-SSD 7 days; p<0.01), but their outpatient treatment period was significantly longer (medians: hydrofiber 12 days, SSD 6 and CN-SSD 4 days; p<0.01). The proportion of surgeries and the mean time to surgery was similar between the burn centers.
Conclusions: This study compared different burn centers' treatment strategies for children with partial-thickness scalds and found a shorter time to wound healing in the CN-SSD group. Patients treated with hydrofiber had a shorter clinical period in comparison with the SSD and CN-SSD patients. The results of CN-SSD are promising and warrant further study. A prospective study is needed to gain full insight into the merits and drawbacks of the treatment strategies. This will allow clinicians to make full use of the strengths of particular treatments to benefit specific patients.
Keywords: Cerium nitrate-silver sulfadiazine; Hydrofiber; Partial-thickness burns; Scalds; Silver sulfadiazine.
Copyright © 2016 Elsevier Ltd and ISBI. All rights reserved.
Similar articles
-
Reduction in skin grafting after the introduction of hydrofiber dressings in partial thickness burns: a comparison between a hydrofiber and silver sulphadiazine.Burns. 2013 Feb;39(1):130-5. doi: 10.1016/j.burns.2012.03.004. Epub 2012 Apr 4. Burns. 2013. PMID: 22480921
-
A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.Int Wound J. 2010 Aug;7(4):271-6. doi: 10.1111/j.1742-481X.2010.00690.x. Epub 2010 May 28. Int Wound J. 2010. PMID: 20528992 Free PMC article. Clinical Trial.
-
Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.J Med Assoc Thai. 2009 Oct;92(10):1300-5. J Med Assoc Thai. 2009. PMID: 19845237 Clinical Trial.
-
Effect of silver-containing hydrofiber dressing on burn wound healing: A meta-analysis and systematic review.J Cosmet Dermatol. 2023 May;22(5):1685-1691. doi: 10.1111/jocd.15639. Epub 2023 Jan 22. J Cosmet Dermatol. 2023. PMID: 36683314
-
Comparative study of Silver Sulfadiazine with other materials for healing and infection prevention in burns: A systematic review and meta-analysis.Burns. 2019 Mar;45(2):282-292. doi: 10.1016/j.burns.2018.05.014. Epub 2018 Jun 11. Burns. 2019. PMID: 29903603
Cited by
-
Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.Pharmaceuticals (Basel). 2021 Feb 28;14(3):201. doi: 10.3390/ph14030201. Pharmaceuticals (Basel). 2021. PMID: 33671009 Free PMC article.
-
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care.Pharmaceutics. 2023 Jan 4;15(1):184. doi: 10.3390/pharmaceutics15010184. Pharmaceutics. 2023. PMID: 36678813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical